tinea pedis

June Clinical Considerations for NPs, PAsThis month, our clinical considerations include articles on the role of the microbe in acne, data around a topical agent to treat tinea pedis, and insights on sebum interacts with airborne pollution.
Tinea pedis treatment tests better than expectedA silicone-based gel with a nitric oxide platform has been found to be safe and efficacious for treating tinea pedis, according to the results of a Phase 2 trial.
Onychomycosis armamentarium set to expand with new optionsOral terbinafine has been the gold standard for treatment of onychomycosis for more than 20 years, but development of new therapeutic options has been the focus of some significant research activity.
FDA approves luliconazole for tinea pedisFDA has approved luliconazole (Luzu Cream, 1%, Valeant Pharmaceuticals) for the 1-week, once-daily treatment of interdigital tinea pedis, tinea cruris, and tinea corporis, caused by the organisms Trichophyton rubrum and Epidermophyton floccosum, in patients aged 18 years and older.
FDA approves luliconazole for tinea pedisThe Food and Drug Administration has approved luliconazole (Luzu Cream, 1 percent, Valeant Pharmaceuticals) for the two-week, once-daily treatment of interdigital tinea pedis, tinea cruris, and tinea corporis, caused by the organisms Trichophyton rubrum and Epidermophyton floccosum, in patients ages 18 and older.